Adaptive Biotechnologies (ADPT) Tops Q2 EPS by 7c
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $27.82 -0.86%
Revenue Growth %: -23.8%
Financial Fact:
Benefit from (provision for) income taxes: 2.06M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: -23.8%
Financial Fact:
Benefit from (provision for) income taxes: 2.06M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Adaptive Biotechnologies (NASDAQ: ADPT) reported Q2 EPS of ($0.17), $0.07 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $58.88 million versus the consensus estimate of $49.4 million.
For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Senior Iranian Official To Reuters: Tehran Is Reviewing U.S. Response To Its Proposal To End Hostilities
- Smith+Nephew launches EVOS Pelvic Plating System in the US
- Scotiabank Reiterates Sector Outperform Rating on Ero Copper Corp. (ERO:CN) (ERO)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
